Source:http://linkedlifedata.com/resource/pubmed/id/20939753
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2010-10-13
|
pubmed:abstractText |
Partial liquid ventilation (PLV) with perfluorocarbons may cause pulmonary recruitment in acute lung injury (ALI). Semi-fluorinated alkanes (SFAs) provide biochemical properties similar to perfluorocarbons. Additionally, SFAs are characterized by increased lipophilicity. Therefore, SFA-PLV may be considered for deposition of certain therapeutic drugs into atelectatic lung areas. In this experimental study SFA-PLV was evaluated to demonstrate feasibility, pulmonary recruitment, and efficacy of drug deposition. Feasibility of SFA-PLV was determined in pigs with and without experimental ALI. Animals were randomized to PLV with SFAs up to a cumulative amount of 30 mL x kg?¹ or to conventional mechanical ventilation. Pulmonary recruitment effects were determined by analyzing ventilation-perfusion distributions. Efficacy of intrapulmonary drug deposition was evaluated in further experiments by measuring drug serum concentrations in the course of PLV with SFA-dissolved ?-tocopherol and ibuprofen. Increasing SFA doses caused progressive reduction of intrapulmonary shunt in animals with ALI, indicating pulmonary recruitment. PLV with SFA-dissolved ?-tocopherol had no effect on serum levels of ?-tocopherol, whereas PLV with SFA-dissolved ibuprofen caused a rapid increase of serum levels of ibuprofen. The authors conclude that SFA-PLV is feasible and causes pulmonary recruitment in ALI. Effectiveness of drug deposition in the lung obviously depends on the partitioning drugs out of the SFA phase into blood.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1521-0499
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
499-507
|
pubmed:meshHeading |
pubmed-meshheading:20939753-Acute Lung Injury,
pubmed-meshheading:20939753-Animals,
pubmed-meshheading:20939753-Disease Models, Animal,
pubmed-meshheading:20939753-Drug Carriers,
pubmed-meshheading:20939753-Drug Delivery Systems,
pubmed-meshheading:20939753-Female,
pubmed-meshheading:20939753-Fluorocarbons,
pubmed-meshheading:20939753-Hemodynamics,
pubmed-meshheading:20939753-Ibuprofen,
pubmed-meshheading:20939753-Liquid Ventilation,
pubmed-meshheading:20939753-Lung,
pubmed-meshheading:20939753-Respiratory Insufficiency,
pubmed-meshheading:20939753-Swine,
pubmed-meshheading:20939753-alpha-Tocopherol
|
pubmed:year |
2010
|
pubmed:articleTitle |
Semi-fluorinated alkanes as carriers for drug targeting in acute respiratory failure.
|
pubmed:affiliation |
Department of Intensive Care Medicine, RWTH University Hospital Aachen, Germany. rolf.dembinski@post.rwth-aachen.de
|
pubmed:publicationType |
Journal Article
|